Literature DB >> 2362832

GST1 gene deletion determined by polymerase chain reaction.

K E Comstock1, B J Sanderson, G Claflin, W D Henner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2362832      PMCID： PMC331054          DOI： 10.1093/nar/18.12.3670

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  4 in total

1.  Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.

Authors:  J Seidegård; W R Vorachek; R W Pero; W R Pearson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

2.  Gene expression of rat glutathione S-transferases. Evidence for gene conversion in the evolution of the Yb multigene family.

Authors:  H C Lai; B Qian; G Grove; C P Tu
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

3.  Hereditary interindividual differences in the glutathione transferase activity towards trans-stilbene oxide in resting human mononuclear leukocytes are due to a particular isozyme(s).

Authors:  J Seidegård; J W DePierre; R W Pero
Journal:  Carcinogenesis       Date:  1985-08       Impact factor: 4.944

4.  A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer.

Authors:  J Seidegård; R W Pero; D G Miller; E J Beattie
Journal:  Carcinogenesis       Date:  1986-05       Impact factor: 4.944
  4 in total
  14 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

Review 2.  Molecular basis of polymorphic drug metabolism.

Authors:  A K Daly
Journal:  J Mol Med (Berl)       Date:  1995-11       Impact factor: 4.599

3.  Association of p53 genomic instability with the glutathione S-transferase null genotype in gastric cancer in the Portuguese population.

Authors:  A R Conde; G Martins; C Saraiva; J Rueff; C Monteiro
Journal:  Mol Pathol       Date:  1999-06

4.  Quantifying heterogeneity in exposure-risk relationships using exhaled breath biomarkers for 1,3-butadiene exposures.

Authors:  Thomas J Smith; Frederic Y Bois; Yu-Sheng Lin; Celine Brochot; Sandrine Micallef; David Kim; Karl T Kelsey
Journal:  J Breath Res       Date:  2008-09-08       Impact factor: 3.262

5.  Placental anti-oxidant gene polymorphisms, enzyme activity, and oxidative stress in preeclampsia.

Authors:  J Zhang; M Masciocchi; D Lewis; W Sun; A Liu; Y Wang
Journal:  Placenta       Date:  2008-04-02       Impact factor: 3.481

6.  Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.

Authors:  K A McGlynn; E A Rosvold; E D Lustbader; Y Hu; M L Clapper; T Zhou; C P Wild; X L Xia; A Baffoe-Bonnie; D Ofori-Adjei
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

7.  Detection of GST1 gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese.

Authors:  S Harada; S Misawa; T Nakamura; N Tanaka; E Ueno; M Nozoe
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

8.  Glutathione S-transferase class mu in French alcoholic cirrhotic patients.

Authors:  A Groppi; C Coutelle; B Fleury; A Iron; J Begueret; P Couzigou
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

9.  Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.

Authors:  M V González; V Alvarez; M F Pello; M J Menéndez; C Suárez; E Coto
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

10.  Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase mu.

Authors:  D A Bell; C L Thompson; J Taylor; C R Miller; F Perera; L L Hsieh; G W Lucier
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.